PHS FOI 2023-001544
- Date of request
- 23 March 2023
- Date of response
- 10 April 2023
- FOI request ID
- PHS FOI 2023-001544
- Pharmacy and prescribing
Request
“I am conducting analysis on the treatment of breast cancer and would be grateful if you send me an extract from the Hospital Medicines Utilisation Database (HMUD). I have included a specification on page 2 of this letter. Please send the response as Excel or .csv file.
HMUD fields to include in the data extract:
|
Field |
|
Example (for example only) |
|
Calendar year |
|
2023 |
|
Calendar month |
|
Jan |
|
Name of Health Board |
|
NHS Lothian |
|
Drug substance (INN name of drug) |
|
abemaciclib |
|
Drug product pack name |
Virtual or actual product pack name, whichever are stored in HMUD |
Abemaciclib 100mg tablets or Abemaciclib 150mg tablets or Abemaciclib 50mg tablets |
|
Quantity unit of measure (UOM) |
e.g. tablet, mL, vial, the unit in which the quantity can be measured |
tablet |
|
Quantity issued |
|
numerical value |
Filters
- Time period: start of Jan 2021 to end Jan 2023
- Drugs
- Abemaciclib (Verzenios)
- Palbociclib (Ibrance)
- Ribociclib (Kisqali)
- Alpelisib (Piqray)
- Anastrozole (anastrozole or Arimidex)
- Exemestane (exemestane or Aromasin)
- Fulvestrant (fulvestrant or Faslodex)
- Letrozole (letrozole or Femara)”